On-chip wavelength multiplexed detection of cancer DNA biomarkers in blood

  • H. Cai
  • , M. A. Stott
  • , D. Ozcelik
  • , J. W. Parks
  • , A. R. Hawkins
  • , H. Schmidt

Research output: Journal article publicationJournal articleAcademic researchpeer-review

Abstract

We have developed an optofluidic analysis system that processes biomolecular samples starting from whole blood and then analyzes and identifies multiple targets on a silicon-based molecular detection platform. We demonstrate blood filtration, sample extraction, target enrichment, and fluorescent labeling using programmable microfluidic circuits. We detect and identify multiple targets using a spectral multiplexing technique based on wavelength-dependent multi-spot excitation on an antiresonant reflecting optical waveguide chip. Specifically, we extract two types of melanoma biomarkers, mutated cell-free nucleic acids -BRAFV600E and NRAS, from whole blood. We detect and identify these two targets simultaneously using the spectral multiplexing approach with up to a 96% success rate. These results point the way toward a full front-to-back chip-based optofluidic compact system for high-performance analysis of complex biological samples.

Original languageEnglish
Article number064116
JournalBiomicrofluidics
Volume10
Issue number6
DOIs
Publication statusPublished - 1 Nov 2016
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

ASJC Scopus subject areas

  • Biomedical Engineering
  • General Materials Science
  • Condensed Matter Physics
  • Fluid Flow and Transfer Processes
  • Colloid and Surface Chemistry

Fingerprint

Dive into the research topics of 'On-chip wavelength multiplexed detection of cancer DNA biomarkers in blood'. Together they form a unique fingerprint.

Cite this